Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Baxter International Inc (BAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,552,272
  • Shares Outstanding, K 532,140
  • Annual Sales, $ 10,561 M
  • Annual Income, $ 717,000 K
  • 36-Month Beta 0.96
  • Price/Sales 3.36
  • Price/Cash Flow 17.03
  • Price/Book 3.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.73
  • Number of Estimates 9
  • High Estimate 0.74
  • Low Estimate 0.71
  • Prior Year 0.64
  • Growth Rate Est. (year over year) +14.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.40 +10.71%
on 12/24/18
68.04 -0.10%
on 01/16/19
+2.28 (+3.46%)
since 12/14/18
3-Month
61.05 +11.34%
on 10/31/18
72.54 -6.29%
on 10/17/18
-3.79 (-5.27%)
since 10/16/18
52-Week
61.05 +11.34%
on 10/31/18
78.38 -13.28%
on 09/20/18
+0.31 (+0.45%)
since 01/16/18

Most Recent Stories

More News
Will Instruments Fuel Intuitive Surgical (ISRG) Q4 Earnings?

Intuitive Surgical's (ISRG) top line in the fourth quarter of 2018 is likely to benefit from solid grow that the Instruments and Accessories segment.

BAX : 67.97 (+0.64%)
ISRG : 517.17 (+0.33%)
DXCM : 146.72 (-0.22%)
PKI : 82.40 (+0.05%)
Varian Medical (VAR) to Report Q1 Earnings: What's in Store?

Strong overseas presence and product launches are likely to aid Varian Medical's (VAR) fiscal first-quarter results.

VAR : 126.07 (+1.11%)
BAX : 67.97 (+0.64%)
DXCM : 146.72 (-0.22%)
PKI : 82.40 (+0.05%)
Stock Market News For Jan 8, 2019

Wall Street rallied for the second consecutive day on Monday after resumption of trade related negotiations between the United States and China

NFLX : 350.05 (-1.29%)
UNP : 151.89 (-0.39%)
ABMD : 326.36 (+0.23%)
BAX : 67.97 (+0.64%)
QEP : 8.64 (-1.37%)
AMZN : 1,681.44 (+0.41%)
Baxter's PD Solution to Treat Patients, Prospects Bright

Baxter's (BAX) kidney care portfolio likely to favor the company as kidney care demand shoots up in the United States.

VEEV : 100.85 (-0.54%)
BAX : 67.97 (+0.64%)
FMS : 34.70 (+1.37%)
DVA : 57.41 (+1.13%)
Can Baxter (BAX) Keep the Earnings Surprise Streak Alive?

Baxter (BAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

BAX : 67.97 (+0.64%)
Baxter Signs Open Data Pledge to Improve Patient Safety

The Patient Safety Movement Foundation (PSMF) announced today that Baxter International Inc. (NYSE:BAX), a global medical products company, has signed the PSMF's Open Data Pledge as...

BAX : 67.97 (+0.64%)
Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III

Mallinckrodt (MNK) and partner NPXe Limited enrol the first patient in the phase III study on xenon gas for inhalation (XENEX) for Post Cardiac Arrest Syndrome (PCAS).

MDCO : 20.10 (+1.31%)
BAX : 67.97 (+0.64%)
GILD : 68.05 (-0.69%)
MNK : 20.16 (+1.05%)
Baxter to Host Fourth Quarter 2018 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth quarter 2018 financial results on Thursday, January 31,...

BAX : 67.97 (+0.64%)
New Research: Key Drivers of Growth for Baxter International, Sempra Energy, Nielsen Holdings Plc, ARRIS International plc, Ionis Pharmaceuticals, and KB Home -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Baxter International Inc. (NYSE:BAX),...

KBH : 20.84 (+0.48%)
SRE : 112.52 (-0.03%)
BAX : 67.97 (+0.64%)
IONS : 57.72 (-0.93%)
ARRS : 30.95 (+0.19%)
NLSN : 25.30 (+0.96%)
Stock Market News For Dec 19, 2018

U.S. stocks closed mostly higher on Tuesday after a volatile session, reversing stiff decline in previous two trading days

CVX : 111.25 (-0.78%)
FANG : 104.35 (-0.63%)
XOM : 71.62 (-0.07%)
BAX : 67.97 (+0.64%)
FDX : 172.52 (+1.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade BAX with:

Business Summary

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare...

See More

Key Turning Points

2nd Resistance Point 68.57
1st Resistance Point 68.05
Last Price 67.97
1st Support Level 66.60
2nd Support Level 65.67

See More

52-Week High 78.38
Fibonacci 61.8% 71.76
Fibonacci 50% 69.71
Last Price 67.97
Fibonacci 38.2% 67.67
52-Week Low 61.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar